Cargando…

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease

BACKGROUND: Bacterial colonisation in chronic obstructive pulmonary disease (COPD) contributes to airway inflammation and modulates exacerbations. We assessed risk factors for bacterial colonisation in COPD. METHODS: Patients with stable COPD consecutively recruited over 1 year gave consent to provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Marín, Alicia, Monsó, Eduard, Vilà, Sara, de la Roza, Cristian, Hervás, Ramona, Esquinas, Cristina, García, Marian, Millares, Laura, Morera, Josep, Torres, Antoni
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883541/
https://www.ncbi.nlm.nih.gov/pubmed/20470372
http://dx.doi.org/10.1186/1465-9921-11-58
Descripción
Sumario:BACKGROUND: Bacterial colonisation in chronic obstructive pulmonary disease (COPD) contributes to airway inflammation and modulates exacerbations. We assessed risk factors for bacterial colonisation in COPD. METHODS: Patients with stable COPD consecutively recruited over 1 year gave consent to provide a sputum sample for microbiologic analysis. Bronchial colonisation by potentially pathogenic microorganisms (PPMs) was defined as the isolation of PPMs at concentrations of ≥10(2 )colony-forming units (CFU)/mL on quantitative bacterial culture. Colonised patients were divided into high (>10(5 )CFU/mL) or low (<10(5 )CFU/mL) bacterial load. RESULTS: A total of 119 patients (92.5% men, mean age 68 years, mean forced expiratory volume in one second [FEV(1)] [% predicted] 46.4%) were evaluated. Bacterial colonisation was demonstrated in 58 (48.7%) patients. Patients with and without bacterial colonisation showed significant differences in smoking history, cough, dyspnoea, COPD exacerbations and hospitalisations in the previous year, and sputum colour. Thirty-six patients (62% of those colonised) had a high bacterial load. More than 80% of the sputum samples with a dark yellow or greenish colour yielded PPMs in culture. In contrast, only 5.9% of white and 44.7% of light yellow sputum samples were positive (P < 0.001). Multivariate analysis showed an increased degree of dyspnoea (odds ratio [OR] = 2.63, 95% confidence interval [CI] 1.53-5.09, P = 0.004) and a darker sputum colour (OR = 4.11, 95% CI 2.30-7.29, P < 0.001) as factors associated with the presence of PPMs in sputum. CONCLUSIONS: Almost half of our population of ambulatory moderate to very severe COPD patients were colonised with PPMs. Patients colonised present more severe dyspnoea, and a darker colour of sputum allows identification of individuals more likely to be colonised.